A Study With Tarceva and Chemotherapy vs. Chemotherapy Alone in Patients With Advanced Lung Cancer

NCT00047736 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Tarceva (erlotinib HCl)

Sponsor

Genentech, Inc.